Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine versus venlafaxine for depression with physical symptoms
ChiCTR1900026697Phase 4Not yet recruiting
- Sponsor
- Peking University Sixth Hospital
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in major depressive disorder (MDD) comparing Vortioxetine arm with Venlafaxine sustained-release arm (2 arms). Primary endpoints: Physical symptoms, Cognitive function and 1 more. Planned start Jul 2019; status: not yet recruiting.
02
Drugs
vortioxetinevenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR1900026697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026697.